Benin vs Kazakhstan: Previously treated cases tested for RR-/MDR-TB
Benin
100.0%
in 2024
Kazakhstan
100.0%
in 2024
Benin rank
1st
Kazakhstan rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Benin
- Kazakhstan
How they compare
Benin currently reports 100.0% against 100.0% in Kazakhstan, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2006 it was Kazakhstan ahead.
Benin ranks 1st and Kazakhstan ranks 1st of 180 countries.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Benin | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 40.0% | 49.3% | 9.3% | Kazakhstan |
| 2010s | 75.9% | 87.4% | 11.5% | Kazakhstan |
| 2020s | 99.0% | 100.0% | 1.0% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Benin or Kazakhstan?
- Benin, at 100.0% against 100.0% in Kazakhstan as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Benin and Kazakhstan?
- 0.0%, with Benin ahead.
- How many years of comparable data are there for Benin and Kazakhstan?
- 18 years are reported by both, from 2006 to 2024.
- How do Benin and Kazakhstan rank globally for previously treated cases tested for rr-/mdr-tb?
- Benin ranks 1st and Kazakhstan ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.